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Abstract
A unique low density lipoprotein was obtained from the tumor transplanted with a cultured
cell line of Ehrlich ascites tumor, JTC-ll cell. The tumor low density lipoprotein electrophoret-
ically migrated as a single band, and the mobility was different from that of other organs. The
chemical composition of lipid, cholesterol and phospholipids in tumor low density lipoprotein
were characteristic. The flotation rate was Sf 5.9, and thus the molecular weight was estimated
to be about 130 x 104. The inhibitory effect on tumor growth of the immune serum was most
elevated at 25th day after the intraperitoneal administration of tumor low density lipoprotein. The
main fraction effective for inhibition of tumor growth existed in γ-globulin.
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Tumor specific antigenicity has been clarified from the aspect of
genetical compatible host. It has been discovered by FOLEY (l) and has
been confirmed by PREHN (2), and KLEIN (3) that methylcholanthrene-
induced sarcomas in mice are strongly antigenic. They reported that the
antigenicity was tumor specific and that it did not depend on genetically
determined isoantigenic differences between donor and recipient. In the
previous report (4), the antitumor activity of regional lymph node protein
of mice transplanted with a cultured cell line of Ehrlich ascites tumor,
]TC-II cell, was demonstrated.
In the present experiment, the low density lipoprotein in tumor of
dd mice transplanted with ]TC-II cells was prepared by dextran sulfate
precipitation method. Tumor low density lipoprotein showed a single
band in electrophoresis, and the chemical characters were different from
those of other organs. The growth inhibitory effect was observed in vitro
cultured JTC-II cells by the serum immunized with the tumor low density
Iipoprotein.
EXPERIMENTALS
Materials: Albino dd mice weighing about 20 g were inoculated sub-
cutaneously with a cultured cell line of Ehrlich ascites tumor, ]TC-II cell,
as described previously (4). The tumors grown to the size of about a little
finger tip on 10th day after transplantation were collected in pool, about
100 g in wet weight, minced in a Waring blender, and then homogenized
in a glass-Teflon homogenizer in 10 volumes of 0.01 M phosphate buffer
containing O. 15 M NaCl, pH 7 .6. Tumor homogenate was centrifuged at
140, 000 x g for 2 hrs in a Hitachi Preparative Ultracentrifuge, Model 40
P. Low density lipoprotein was prepared by dextran sulfate precipitation
method from the supernatant solution (5), and high density lipoprotein
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was obtained from the precipitate according to the method of MANSON
et al. (6). Dextran sulfate (molecular weight; about 2 X 105), protamine
sulfate and DEAE-Sephadex A·50 were purchased from Pharmacia Upp-
sala, Sweden. Other reagents used were all of reagent grade purchased
from Wako Pure Chemicals Co., Daiichi Pure Chf"micals Co. and Merk
Co.
Chemical Analysis: The concentration of lipoprotein was determined
by the colorimetric method of LOWRY et al. (7), combined at 280 mp..
The concentration of low density lipoprotein was corrected by micro.
Kjeldahl method using the insoluble peptide residue of delipidated lipo.
protein. The factors for correction were 0.76 for serum low density lipo
protein, 0.80 for liver, and 0.82 for tumor.
Delipidation: All procedures were carried out at room temperature.
One volume of low density lipoprotein was added slowly to 15 volumes of
methylal-methanol (4: 1, vIv), and the solution was allowed to stand for
at least 2 hrs. The insoluble part was separated by centrifugation for 15
mins, and it was resuspended twice in 5 volumes of acetone, and finally
in 10 volumes of acetone-water (2: I, v/v).
Lipid Analysis: Total lipid content was determined by the method of
BRAGDON (8). Cholesterol was determined by the procedure SCHOENHEIMER-
SPERRY (9, 10), and lipid phosphorus was by FISKE·SUBBAROW (11). The
factor 25 was used to convert lipid phosphorus to phospholipid. Neutral
lipid was estimated substracting cholesterol and phospholipid from total
lipid content. The lipids were separated on thin layer chromatography
(12, 13).
Ultracentrifugation: Ultracentrifugal analysis of low density lipopro.
tein was carried out in about 1.063 density NaCl solution (14). Svedberg
identity was estimated from the flotation rate of tumor low density lipo.
protein, and the molecular weight was calculated according to LINDGREN
et al. (15),
Electrophoresis: Disc electrophoresis on polyacrylamide gel was per-
formed at pH 2.3 with a current of 2.5 rnA per gel column for 90 mins
(16, 17). One of two polyacrylamide gel columns was prestained with
Sudan black B, and the other one was stained with amido black after
migration.
Immune-serum: Albino dd mice were injected intraperitoneally with
1mg protein concentration of low and high density lipoprotein, and 0.5 mg
of lipoprotein was supplemented subcutaneously every 1 week for month.
Immune-serum was obtained on 5, 10, 15, 20, 25, 30, and 40th day after
immunization, and kept at - 20°C. Immune-serum was separated by
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DEAE-Sephadex A-50 column chromatography as described previously (4).
The separated fractions were dialyzed in distilled water, and stored at
- 20°C after lyophilization.
Cell Culture Test: The 2 X 105 or 3 X 106 JTC-ll cells were cultured as
described previously (4). The antitumor activity of immune-serum and its
globulin fraction were determined in vitro cultured JTC-ll cells. The
supernatant of lymph node and spleen homogenate tested the antitumor
activity on 10th day after the intraperitoneal administration of tumor low
density lipoprotein.
RESULTS
Lipid to protein, phospholipid to cholesterol and phospholipid to pro.
tein ratio of low density lipoprotein were shown in Table 1. The ratio of
TABLE 1. CHEMICAL CHARACTERS OF LOW DENSITY LIPOPROTEIN
LDL Total Lipid Protein Phospholipid Cholesterol Phospholipid Protein
'(; Serum 7.4 1.30 1.20
S Liver 4.4 1.22 0.64..
0
Z Spleen 4.6 1.30 0.60
Serum 7.4 1.18 0.76
.. M
o c Liver 4.0 1.06 0.23S'':
:l CIS Spleen 5.2 1.61 0.76r--]
Tumor 5.4 4.08 1.00
Average of 5 mouse experiments
LDL: low density lipoprotein
tumor low density lipoprotein was different from that of normal, and also
that of organs in tumor-bearing mice. The differences between low and
high density lipoprotein of the tumor are clearly shown in Table 2. The
phospholipid to protein ratio of spleen of tumor-bearing mice was greater
than that of normal, and the ratio of tumor also greater than others.
TABLE 2 ANALYSIS OF TUMOR LIPOPROTEIN
Protein
Total Lipid
Neutral Lipid
Phospholipid
LDL
2.46
13.50
9.29
5.26
HDL
7.41
3.49
2.79
0.71
unit=mg/ml Average of 5 mouse experiments
Lipoprotein suspension used for immunizing mice was analyzed.
HDL; High Density Lipoprotein, LDL; Low Density Lipoprotein.
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Ultracentrifugal flotation pattern is shown in Fig, 1. The flotation
rate of tumor low density lipoprotein was Sf 5.9, and the molecular
weight was presumed about 130 X 104 according to LINDGREN.
Fig. 1 Ultracentrifugal analysis of tumor low density lipoprotein. Flotation
rate of tumor low density lipoprotein was analyzed in 1.063 density NaCI solution
at 26°. The peak was observed at 30 min. of 51,2000 rpm, and the Sf was 5,9.
A 2 p
Fig. 2 1) Disc electrophoresis of low density lipoprotein.
A: stained by Amido blac'" P: prestained by Sudan black B.
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2) Disc electrophoresis of low density lipoprotein in mice.
NS = normal mice serum, TS = serum of tumor-bearing mice, NL = low
density lipoprotein from liver of normal mice, TL = low density lipoprotein
from liver of tumor-bearing mice, NM = low density lipoprotein from spleen
of normal mice, TM = low density lipoprotein from spleen of tumor-bearing
mice, T = low density lipoprotein of Ehrlich ascites tumor.
Electrophoretic patterns were shown in Fig. 2. Low density lipoproein
migrated as a single band by prestaining method, and the same mobility
was observed with amido black stain. The electrophoretic mobility of low
density lipoprotein of serum and liver in tumor· bearing mice were slower
than normal ones, and that of spleen were faster than the others. Electro-
phoretic mobility was slowest in tumor tissue. '
Antitumor Activity of Immune·serum: Antitumor activity was examined
in vitro cultured JTC-II cells. Antitumor activities of serum, supernatant
of lymph nodes and spleen homogenate of immunized with low density
lipoprotein are shown in Fig. 3. No significant inhibitory effect on
tumor growth was observed in these of immunized with high density lipo.
protein. Antitumor activity of immune-serum was most elevated at 25th
day after immunization as seen in Fig. 4, and the antitumor activity was
gradually decreased from 30th day or later. Fig. 5 illustrates the relations
between antigenicity and lipoprotein concentration. The highest antigeni.
city was observed by immune·serum obtained from mice injected with
I mg of protein concentration of tumor lipoprotein. Protein concentration
above I mg was unable to examine, because mice administered aove I mg
protein were almost died earlier than 25th day. The antitumor activity of
immune-serum existed mainly in r·globulin fraction separated by DEAE-
Sephadex A·50 column as seen in Fig. 6.
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Fig. 3 Antitumor activity of immune-serum. Normal serum, and the super-
natant of immunized lymph nodes and spleen homoJenate, each I mg/ml protein
concentration, were added for cell culture tubes.
• ; control, X; normal serum, <!); serum immunized with high density lipo-protein, A; supernatant of lymph nodes and spleen immunized with high den-
sity lipoprotein, A; supernatant of lymph nodes and spleen immunized withlow density lipoprotein, 0; serum immunized with low density lipoprotein.
DISCUSSION
The cell culture technique to prove the tumor cytotoxicity was report-
ed by MATUMOTO (18), that rabbit immune-serum produced by lipopoly-
saccharide was specific for the cultured cell growth. BJORKLUND (19) also
reported thas the specific antigen of HeLa cell was probably existed in
membrane structure lipoprotein.
In the present experiment, the antitumor activity of immune-serum
produced by low density lipoprotein in tumor transplanted with JTC-II
cell was explored with in vitro cultured JTC-II cells.
Tumor low density lipoprotein was especially antigenic, and high
density lipoprotein no antigenic. This suggests that the tumor antigenicity
might not be existed in the protein structure of tumor cell, but in the
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Fig. 4 Antitumor activity of ?'-globulin fraction of immune-serum after
immunization. Immune-serum was obtained on various days after immunization,
and immuno-globulin was precipitated by addition of 5096 ammonium sulfate.
Each 1 mg/ml protein concentration was added in cell culture tube after dialysis.
d = days after immunization.
lipid composition, especially in phospholipids of low density lipoprotein as
illustrated in Table 1, because the phospholipid content and the electro-
phoretic mobility of tumor low density lipoprotein were different from
others. SACKS et al. (20) reported that the electrophoretic mobility of
human serum incubated with soya bean lipoprotein migrated faster than
that of non-treated one. Therefore, the differences of electrophoretic
mobility of low density lipoprotein between normal and tumor-bearing
mice might be concerned with the phospholipid content.
The antitumor activity of immune-serum was most elevated at 25th
day after immunization, and that of lymph nodes and spleen was at 10th
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Fig. 5 Antigenicity of lipoprotein concentration. Immuno-globulin at 25th
dayafter immunization, obtained by immunizing with I mg, 0.5 mg of protein
concentration of tumor lipoprotein, was added in cell culture tube.
day as previously reported (4). These facts suggest that the antibody
formation might be in lymph nodes aJ1.d spleen in 10 days after immuni-
zation, and the immunoglobulin is gradually issued in serum.
In the present experiment, r-globulin fraction of immune-serum acted
as growth inhibitor in vitro cultured ]TC-Il cells. HIRAI (21) reported that
the r-globulin of tumor transplanted rat was decreased, and that of spon-
taneously healing was increased.
In the present experiment, the possibility of antibody formation for
malignant tumor was demonstrated by antigenicity originated from tumor
low density lipoprotein.
CONCLUSION
A unique low density lipoprotein was obtained from the tumor trans-
planted with a cultured cell line of Ehrlich ascites tumor, ]TC-ll cell.
The tumor low density lipoprotein electrophoretically migrated as a single
band, and the mobility was different from that of other organs. The
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Fig. 6 Antitumor activity of immuno-globulin. a·, f3- and I'·globulin fraction
each I mJ/ml protein concentration was added for cell culture tube.
chemical composition of lipid, cholesterol and phospholipids in tumor
low density lipoprotein were characteristic. The flotation rate was Sf 5.9,
and thus the molecular weight was estimated to be about 130 x 104•
The inhibitory effect on tumor growth of the immune serum was most
elevated at 25th day after the intraperitoneal administration of tumor
low density lipoprotein. The main fraction effective for inhibition of
tumor growth existed in r-globulin.
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